Institute events

Tricyclo-DNA : Conception d’oligonucléotides antisens pour le traitement de certaines maladies neuromusculaires par modulation d’épissage Monday 8 October 2018 – 12:00-13:00 Pr. Luis GARCIA (Directeur U1179 UVSQ-INSERM, Handicap Neuromusculaire : Physiologie, Biothérapie et Pharmacologie appliquées, UFR des sciences de la santé Simone Veil, Université de Versailles St. Quentin-en-Yvelines, France) Host : Vincent Mouly Institute of Myology auditorium … [Read more]

After a long break for the summer holidays, welcome to the latest issue of our newsletter!   The Great Family Celebration was an opportunity to look back on 60 years of struggles and victories, and to celebrate advances in research, rights and support for the patients. The kick-off of the Telethon 2018 has also been … [Read more]

For this new 2018 edition of the French science fair, “Fête de la Science”, researchers at the institute offer you to follow step by step the different techniques used to bring new knowledge on the field of muscle and to create the therapies of tomorrow. Where ? Village des Sciences Sorbonne Université 4 place Jussieu … [Read more]

A left ventricular assist device was implanted in two patients with myopathy (Duchenne and Becker), with refractory heart failure and not eligible at this stage for transplantation. In May 2018, Dr. Denis Duboc’s team implanted a left ventricular assist device in two patients, aged 20 and 40, with myopathy (Duchenne and Becker), refractory heart failure … [Read more]

Dr. Teresa Gidaro is the principal investigator for France in the multicentre, WAVE trial that launched in June at I-Motion. This phase I international trial also includes sites from the United Kingdom, the United States and Belgium, where Laurent Servais is the principal investigator at his site in Liège. What is the new molecule investigated … [Read more]

A postdoctoral position is available in the team of Gisèle Bonne (Myology Centre for Research) in the context of a research project supported by MD-UK aiming at the identification of potential genetic modifiers modulating the diseases severity of LMNA-congenital muscular dystrophy and related striated muscle laminopathies using multi-omics approaches. The team has a long standing … [Read more]

Within the EU-H2020 Solve-RD project “Solving the unsolved Rare Diseases” a medical research assistant position is available in the team of Gisèle Bonne. The main ambitions of the Solve-RD proposal are (i) to solve large numbers of Rare Disease cases, for which a molecular cause is not known yet, by combined Omics approaches, (ii) to … [Read more]

In March 2018, Genethon and AveXis concluded an agreement on the patent exploitation filed in 2007 by Martine Barkats concerning her work at Genethon since 2004 (1). Martine Barkats joined the Institute of Myology in 2010. Since then, she and her team have continued their research to develop innovative therapies for motor neuron diseases. From … [Read more]

Impact of chronic inactivity on neuromuscular health Monday 17 September 2018 – 12:00-13:00 Prof. Marco Narici (Dipartimento di Scienze Biomediche, Universita’ di Padova, Italia) Host : Gill Butler-Browne Institute of Myology auditorium Hôpital de la Pitié-Salpêtrière Building Babinski Entrance 82 bd Vincent Auriol metro Chevaleret

A postdoctoral position is available at the Center of Research in Myology, in the team ‘Pathophysiology and therapy of the dynamin 2-related centronuclear myopathy’ headed by Marc Bitoun. Title of the project entitled “Therapy of centronuclear myopathies by modulation of Dynamin 2 expression”   Download the postdoctoral position announcement